NCT04773626

Brief Summary

  1. 1.Assessment of correlation between tumor deposits and clinicopathological characteristics of colorectal cancer.
  2. 2.Detection of association between tumor deposits and stage of colorectal cancer.
  3. 3.Evaluate the relationship between tumor deposits and prognosis of colorectal cancer patient.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2021

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 24, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 26, 2021

Completed
3 months until next milestone

Study Start

First participant enrolled

June 1, 2021

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2023

Completed
Last Updated

March 5, 2021

Status Verified

March 1, 2021

Enrollment Period

1.6 years

First QC Date

February 24, 2021

Last Update Submit

March 3, 2021

Conditions

Cancer of Colon

Outcome Measures

Primary Outcomes (1)

  • Evaluate the relationship between tumor deposits and prognosis of colorectal cancer patient.

    1. Assessment of correlation between tumor deposits and clinicopathological characteristics of colorectal cancer. 2. Detection of correlation between tumor deposits and stage of colorectal cancer. 3. Correlation between tumor deposits and prognosis of colorectal cancer, clinicopathological characteristics of colorectal cancer, stage of colorectal cancer".

    2 years

Eligibility Criteria

Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

1. This retrospective study includes primary invasive colorectal carcinoma samples from Egyptian patients that will be retrieved from the registry of Pathology department, South Egypt Cancer Institute and Assiut University Hospital. 2. All patients who underwent resection of colorectal cancer will be included in our study.

You may qualify if:

  • \- 1-This retrospective study includes primary invasive colorectal carcinoma samples from Egyptian patients.
  • Patients who underwent resection of colorectal cancer will be included in our study.

You may not qualify if:

  • All patients who underwent endoscopic biopsies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Peparini N. Beyond T, N and M: The impact of tumor deposits on the staging and treatment of colorectal and gastric carcinoma. Surg Oncol. 2018 Jun;27(2):129-137. doi: 10.1016/j.suronc.2018.02.007. Epub 2018 Feb 21.

    PMID: 29937162BACKGROUND

MeSH Terms

Conditions

Colonic Neoplasms

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal Diseases

Central Study Contacts

Naglaa Fathi, Master

CONTACT

0201096134165naglaafathi600@gmail.com

mahmoud gamal

CONTACT

0201009335537Mahmoudameengamal@aun.edu.eg

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident doctor

Study Record Dates

First Submitted

February 24, 2021

First Posted

February 26, 2021

Study Start

June 1, 2021

Primary Completion

January 1, 2023

Study Completion

April 1, 2023

Last Updated

March 5, 2021

Record last verified: 2021-03